Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Achieve Life Sciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $490.99M | $349.29M - $632.69M | $0.00 | $2.504 | 6 |
| Dec 2029 | $332.82M | $236.77M - $428.88M | $0.00 | $1.438 | 3 |
| Dec 2028 | $153.20M | $153.17M - $153.24M | $0.00 | $0.287 | 7 |
| Dec 2027 | $45.07M | $26.39M - $63.75M | $0.00 | -$0.461 | 6 |
| Dec 2026 | $4.50M | $4.25M - $4.75M | $0.00 | -$0.715 | 6 |
| Dec 2025 | $16.42M | $11.68M - $21.15M | $0.00 | -$1.276 | 5 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.221 | 0 |
| Dec 2022 | $100.0K | $84.7K - $113.6K | $0.00 | -$4.065 | 3 |
| Dec 2021 | $40.0K | $33.9K - $45.4K | $0.00 | -$3.92 | 2 |
| Dec 2017 | $4.50M | $3.81M - $5.11M | $0.00 | -$1,936.00 | 2 |
| Dec 2016 | $4.78M | $4.05M - $5.43M | $0.00 | -$1,870.00 | 3 |
| Dec 2015 | $19.78M | $16.76M - $22.46M | $0.00 | -$1,991.00 | 2 |